Alyssa Wyant

Alyssa Wyant has served as the Chief Regulatory and Quality Officer since December 2021. Previously, she served as Senior Vice President of Regulatory and Quality from September 2020 to November 2021. Prior to joining us, Ms. Wyant was at EryDel S.p.A, where she served as Senior Vice President, Regulatory Affairs from January 2019 to August 2020. Prior to joining EryDel S.p.A, Ms. Wyant held senior leadership roles at Edge Therapeutics, Inc. and PTC Therapeutics, Inc. Ms. Wyant brings more than 20 years of regulatory affairs experience to Praxis, including having led the creation and implementation of global strategies for the development, registration, and post-approval activities for numerous approved products across both CNS and rare diseases. Ms. Wyant received a B.S. in cell and molecular biology from the University of Washington.